Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 489, pseudogene (RN7SL489P) is a human non-coding RNA pseudogene belonging to the family of 7SL RNA-derived sequences. Over several hundred such 7SL-like sequences are dispersed through human DNA, but the vast majority, including RN7SL489P, are classified as pseudogenes. These do not encode functional RNA or protein products and are generally considered genetic relics, arising from reverse transcription of the functional 7SL RNA and integration back into the genome. They are typically truncated or mutated, and RN7SL489P has no known biological function, protein product, or role as a druggable therapeutic target[6][3][4][7]. It is not a protein-coding gene, has no known receptor or enzymatic activity, and does not function as a cellular target[6][3][4][7]. The 7SL RNA family is part of the signal recognition particle (SRP), a ribonucleoprotein complex essential for targeting proteins to the endoplasmic reticulum, but pseudogenes such as RN7SL489P do not participate in this process[1][3][4][6]. While some pseudogenes in other families have been implicated in regulatory mechanisms or disease, there is no evidence linking RN7SL489P specifically to any disease roles or therapeutic applications[2][6]. The sole listed alias is its gene symbol; no alternative names are in broad use[6]. The molecular class is best described as "Other" (pseudogene), being a non-coding, nonfunctional genomic locus[6][3]. RN7SL489P is a nonfunctional, non-coding RNA pseudogene in the human genome derived from the 7SL RNA family, lacking any biological function, disease association, targetability, or pharmacological relevance[6][3][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 489, pseudogene (RN7SL489P).